Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Addex Therapeutics Ltd. Sponsored ADR (ADXN : NSDQ)
 
 • Company Description   
Addex Therapeutics Ltd is a clinical-stage pharmaceutical company. It is focused on the development and commercialization of small molecule drugs for neurological disorders. The company's lead drug candidate includes dipraglurant, ADX71149 which are in clinical stage. Its Preclinical programs include GABAB PAM for CMT1A, mGlu7 NAM for PTSD, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson's disease and mGlu3 PAM for neurodegenerative disorders. GABAB PAM program has been licensed to Indivior PLC for the treatment of addiction. Addex Therapeutics Ltd is based in Geneva, Switzerland.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $8.94 Daily Weekly Monthly
20 Day Moving Average: 14,051 shares
Shares Outstanding: 1.06 (millions)
Market Capitalization: $9.47 (millions)
Beta: 1.65
52 Week High: $13.27
52 Week Low: $6.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 10.19% 6.06%
12 Week 19.20% 0.26%
Year To Date 27.71% 19.60%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
CHEMIN DES MINES 9
-
GENEVA,V8 CH-1202
CHE		 ph: 011-41-22-884-1555
fax: 41-22-884-1556		 investor.relations@addextherapeutics.com http://www.addextherapeutics.com/en
 
 • General Corporate Information   
Officers
Tim Dyer - Chief Executive Officer
Vincent Lawton - Chairman
Raymond Hill - Director
Isaac Manke - Director
Jake Nunn - Director

Peer Information
Addex Therapeutics Ltd. Sponsored ADR (GSAC)
Addex Therapeutics Ltd. Sponsored ADR (CASI)
Addex Therapeutics Ltd. Sponsored ADR (ALCD.)
Addex Therapeutics Ltd. Sponsored ADR (OMNN)
Addex Therapeutics Ltd. Sponsored ADR (CGPI.)
Addex Therapeutics Ltd. Sponsored ADR (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 00654J206
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 09/29/25
Share - Related Items
Shares Outstanding: 1.06
Most Recent Split Date: 10.00 (0.05:1)
Beta: 1.65
Market Capitalization: $9.47 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.03
Price/Cash Flow: -
Price / Sales: 34.28
EPS Growth
vs. Year Ago Period: 2.92%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -70.63%
vs. Previous Quarter: 3,291.29%
ROE
06/30/25 - -
03/31/25 - -54.27
12/31/24 - -61.65
ROA
06/30/25 - -
03/31/25 - -49.15
12/31/24 - -49.42
Current Ratio
06/30/25 - -
03/31/25 - 3.02
12/31/24 - 4.42
Quick Ratio
06/30/25 - -
03/31/25 - 3.02
12/31/24 - 4.42
Operating Margin
06/30/25 - -
03/31/25 - -2,307.03
12/31/24 - -1,196.15
Net Margin
06/30/25 - -
03/31/25 - 3,584.49
12/31/24 - 1,717.88
Pre-Tax Margin
06/30/25 - -
03/31/25 - -2,307.03
12/31/24 - -1,215.03
Book Value
06/30/25 - -
03/31/25 - 8.71
12/31/24 - 10.37
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©